Stock listing

ASND Stock Price, News, Filings & Events — Ascendis Pharma A/s

Selected listing: ASND · BOATS · USD · US

This page tracks Ascendis Pharma A/s's ASND:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ASND:BOATS. ASND:BOATS is the stock-level entry point for investors researching Ascendis Pharma A/s, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ascendis Pharma A/S is a publicly traded company listed under the ticker ASND, operating in the American market. The company has a market capitalization of approximately $15.83 billion. Ascendis Pharma focuses on developing innovative therapies to address unmet medical needs.

ASND:BOATSUSDUSUpdated September 19, 2026
Ascendis Pharma A/s logo
Ticker
ASND:BOATS
Asset type
Stock
Market cap
$14.77B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

Ascendis Pharma A/s ASND:BOATS stock context

This page tracks Ascendis Pharma A/s's ASND:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ASND:BOATS. ASND:BOATS is the stock-level entry point for investors researching Ascendis Pharma A/s, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ascendis Pharma A/S is a publicly traded company listed under the ticker ASND, operating in the American market. The company has a market capitalization of approximately $15.83 billion. Ascendis Pharma focuses on developing innovative therapies to address unmet medical needs.

Latest news from Ascendis Pharma A/s

All Ascendis Pharma A/s news →

Ascendis Pharma A/s earnings calls

Research Ascendis Pharma A/s

Alternate listings